A Ghattas

A Schlitt

AM Zawada

AS Jaipersad

C Poitou

E Shantsila

G Thomas

GE Rice

H Reinecke

H Tsujioka

I Hilgendorf

J Cros

JF Dopheide

KE Berg

KS Rogacev

M Nylaende

M Wildgruber

MA Ingersoll

P Dutta

P Libby

RB Rutherford

RL Pande

S Sugiyama

SH Schirmer

T Gary

T Ulyanova

Scientific Reports

AbstractMonocytes are key players in atherosclerotic. Human monocytes display a considerable heterogeneity and at least three subsets can be distinguished. While the role of monocyte subset heterogeneity has already been well investigated in coronary artery disease (CAD), the knowledge about monocytes and their heterogeneity in peripheral artery occlusive disease (PAOD) still is limited. Therefore, we aimed to investigate monocyte subset heterogeneity in patients with PAOD. Peripheral blood was obtained from 143 patients suffering from PAOD (Rutherford stage I to VI) and three monocyte subsets were identified by flow cytometry: CD14++CD16− classical monocytes, CD14+CD16++ non-classical monocytes and CD14++CD16+ intermediate monocytes. Additionally the expression of distinct surface markers (CD106, CD162 and myeloperoxidase MPO) was analyzed. Proportions of CD14++CD16+ intermediate monocyte levels were significantly increased in advanced stages of PAOD, while classical and non-classical monocytes displayed no such trend. Moreover, CD162 and MPO expression increased significantly in intermediate monocyte subsets in advanced disease stages. Likewise, increased CD162 and MPO expression was noted in CD14++CD16− classical monocytes. These data suggest substantial dynamics in monocyte subset distributions and phenotypes in different stages of PAOD, which can either serve as biomarkers or as potential therapeutic targets to decrease the inflammatory burden in advanced stages of atherosclerosis.</jats:p

Moritz Wildgruber

Teresa Aschenbrenner

Heiko Wendorff

Maria Czubba

Almut Glinzer

Bernhard Haller

Matthias Schiemann

Alexander Zimmermann

Hermann Berger

Hans-Henning Eckstein

Reinhard Meier

Walter A. Wohlgemuth

Peter Libby

Alma Zernecke

Crossref

The “Intermediate” CD14++CD16+ monocyte subset increases in severe peripheral artery disease in humans

The “Intermediate” CD14++CD16+ monocyte subset increases in severe peripheral artery disease in humans

Abstract

Similar works

Full text

Available Versions

Crossref